Clinical trial for Obstructive Sleep Apnea Syndrome
Official title Functional Magnetic Resonance Imaging in Patients With Obstructive Sleep Apnea Syndrome
ClinicalTrials.gov ID: NCT05147649
What this study is testing
- What it's testing
- The obstructive sleep apnea syndrome (OSAS) involves recurrent sleep-related upper airways (UA) collapse. UA mechanical properties and neural control are altered, imposing a mechanical load on inspiration.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 75. Healthy volunteers may be eligible.
You may be able to join if
- OSAS patients
- severe OSAS with an Apnea-Hypopnea Index (AHI) \> 30/h
- without CPAP treatment
- Non-OSAS patients
- absence of OSAS (AHI \< 15/h and absence of excessive daytime sleepiness with Epworth score \<11) Non-
You likely can't join if
- pregnant woman according to the positive beta-hCG test result
- left-handed following the laterality questionnaire
- MINI results showing:
- a current mood episode
- a current disorder of the use of psychoactive substances or in the last 6 months (excluding tobacco)
- an eating disorder
See the full eligibility criteria
- OSAS patients
- severe OSAS with an Apnea-Hypopnea Index (AHI) \> 30/h
- without CPAP treatment
- Non-OSAS patients
- absence of OSAS (AHI \< 15/h and absence of excessive daytime sleepiness with Epworth score \<11) Non-
- \< 18 years old
- \>75 years old
- left-handed
- BMI\> 40 kg/m²
- another sleep disorder
- central component of sleep apnea syndrome (central apnea index\> 5 / h)
- current or past neurological pathology
- respiratory pathology (obstructive ventilatory disorder, restrictive ventilatory disorder, hypercapnia)
- MRI contraindication (metallic foreign body, claustrophobia, pregnant woman, etc.)
- taking drugs that can modify the BOLD signal on MRI (psychotropic drugs, vasodilators, vasoconstrictors, etc.),
- uncorrected sensory impairment (vision or hearing)
- protected by law.
- pregnant woman according to the positive beta-hCG test result
- left-handed following the laterality questionnaire
- MINI results showing:
- a current mood episode
- a current disorder of the use of psychoactive substances or in the last 6 months (excluding tobacco)
- an eating disorder
- a diagnosis of bipolar disorder, current or past schizophrenia
The study team makes the final eligibility decision.
Where it's taking place
- Reims, France
Compensation & support
This study's listing mentions compensation or reimbursement.
No amount is published here - ClinicalTrials.gov has no reliable field for payment or travel support. Ask the study team what's actually covered (payment for your time, travel, parking, or other study costs), and never join a trial for the compensation alone.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Reims, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.